Perioperative Care of Breast Reconstruction With Latissimus Dorsi Flap and Tissue Expander: Early Discharge Protocol in a Day Surgery Setting
1 other identifier
observational
40
0 countries
N/A
Brief Summary
The pedicled latissimus dorsi flap is a piece of tissue taken from the back that is used to reconstruct the breast after cancerous tissue is removed. Over the years, improvements in surgical technique and pain control have decreased the length of stay in hospital after this procedure. Recently, early discharge after breast reconstruction using another very similar pedicled flap, called the transverse rectus abdominis flap, was shown to be safe, patient-centered, and associated with significant hospital cost-savings by another Canadian group. With increasing pressure from hospital administrators to weigh financial considerations into treatment decision making, doctors must test cost-saving strategies in order to ensure patient satisfaction and safety. Here, we plan to evaluate patient safety, satisfaction and cost efficacy in breast reconstruction using the pedicled latissimus dorsi myocutaneous flap. We hypothesize that patient care planning can allow for safe and cost-effective same-day discharge and improved patient satisfaction after autologous breast reconstruction using the pedicled latissimus dorsi flap. After nearly 10 successful same-day discharges using this flap, our experience at the Ottawa Hospital suggests that this practice is safe, has increased patient satisfaction scores, decreased narcotic use, no short or long term complications and is more cost effective compared to patients who stay overnight. In the present study, we hope to quantify our results by demonstrating that same day discharge is a cost effective strategy that does not compromise patient safety and satisfaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 31, 2016
CompletedStudy Start
First participant enrolled
June 1, 2016
CompletedFirst Posted
Study publicly available on registry
June 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedJune 7, 2016
May 1, 2016
1 year
May 31, 2016
June 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Conversion rate (from same-day discharge to in-patient care)
24 hours
Patient Satisfaction using Breast-Q questionnaire and Perioperative Care Patient
24 hours
Pain Score
24 hours
Amount of post-operative (24 hours) narcotic usage
24 hours
Secondary Outcomes (3)
Short and Long term complications
24 Hours
Readmission Rate
24 Hours
Cost Savings
24 Hours
Study Arms (1)
Same Day Discharge
Following a Latissimus Dorsi flap reconstruction patients will be offered discharge at 24 hours. Patients successfully discharged within 24 hours of their surgery will be included in the cohort group.
Interventions
If both the physician and patient have no concerns within 24 hours of a Latissimus Dorsi Flap breast reconstruction the patient will be discharged home and enrolled in the cohort group.
Eligibility Criteria
Study population will be females older than 18 years old who undergo breast reconstructive surgery with the Latissimus Dorsi flap.
You may qualify if:
- All patients who undergo breast reconstruction using the latissimus dorsi myocutaneous flap.
You may not qualify if:
- All patients undergoing breast reconstruction without the latissimus dorsi flap.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Plastic Surgeon
Study Record Dates
First Submitted
May 31, 2016
First Posted
June 7, 2016
Study Start
June 1, 2016
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
June 7, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will share
Individual participant data will not be made available. Anonymity will be maintained for all published data.